Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews
1997 • 2,255 citations
A breast cancer prediction model incorporating familial and personal risk factors
2004 • 1,203 citations
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
1996 • 762 citations
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
1999 • 390 citations
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000 • 311 citations
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
2003 • 304 citations
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
2008 • 105 citations
Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study
2008 • 51 citations
Colorado family physicians' knowledge of hereditary breast cancer and related practice.
2001 • 45 citations
Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer
2001 • 40 citations
A rapid fluorescent multiplexed‐PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes
2000 • 34 citations
Evaluation of mathematical models for breast cancer risk assessment in routine clinical use
2007 • 26 citations
Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors.
2001 • 15 citations
Cited By (0)
No citing papers found in database